Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-04

Clinical Trial Update: Immun Checkpoint Washout in Patients With Invasive Ductal Breast Cancer [NA]

View source ↗

Summary

Clinical trial investigating immun checkpoint washout in patients with invasive ductal breast cancer; current status is recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Istanbul Training and Research Hospital | Conditions: Breast Cancer Metastatic, Breast Carcinoma | NA | Status: RECRUITING